PAVmed Inc (NASDAQ:PAVM) shares traded up 9.4% on Friday . The company traded as high as $0.93 and last traded at $0.93, 663,134 shares traded hands during mid-day trading. An increase of 193% from the average session volume of 226,476 shares. The stock had previously closed at $0.85.
Separately, Maxim Group restated a “buy” rating and issued a $3.00 target price on shares of PAVmed in a research report on Friday, November 22nd.
The business has a 50-day simple moving average of $0.89 and a two-hundred day simple moving average of $0.99.
About PAVmed (NASDAQ:PAVM)
PAVmed Inc operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube.
Further Reading: 52 Week Highs and Lows
Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.